These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 6961638)
21. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy. Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592 [TBL] [Abstract][Full Text] [Related]
22. Immunology and the therapeutics of leprosy. Bullock WE Ann Intern Med; 1979 Sep; 91(3):482-4. PubMed ID: 382942 [No Abstract] [Full Text] [Related]
23. Should large lesions of leprosy be considered as "multibacillary" for treatment purposes even if the total number of lesions is less than five? Kumarasinghe SP; Kumarasinghe MP Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):173-4. PubMed ID: 15301583 [No Abstract] [Full Text] [Related]
24. Dapsone-induced methemoglobinemia in leprosy patients. Kaur I; Mehta M; Agnihotri N; Dogra S; Ganguly NK Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):247-9. PubMed ID: 11875770 [No Abstract] [Full Text] [Related]
25. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy. Jing Z; Zhang R; Zhou D; Chen J Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621 [TBL] [Abstract][Full Text] [Related]
26. Multidrug therapy in leprosy. Manglani PR; Arif MA J Indian Med Assoc; 2006 Dec; 104(12):686-8. PubMed ID: 17474286 [TBL] [Abstract][Full Text] [Related]
27. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy. Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335 [TBL] [Abstract][Full Text] [Related]
28. Can leprosy be eradicated with chemotherapy? An evaluation of the Malta Leprosy Eradication Project. Jacobson RR; Gatt P Lepr Rev; 2008 Dec; 79(4):410-5. PubMed ID: 19274987 [TBL] [Abstract][Full Text] [Related]
29. Drugs against leprosy. Rao CK World Health Forum; 1988; 9(1):63-8. PubMed ID: 3254197 [No Abstract] [Full Text] [Related]
30. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone. Sapkota BR; Shrestha K; Pandey B; Walker SL Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989 [TBL] [Abstract][Full Text] [Related]
31. A overview of ocular leprosy after 2 decades of multidrug therapy. Lewallen S; Courtright P Int Ophthalmol Clin; 2007; 47(3):87-101. PubMed ID: 17667278 [No Abstract] [Full Text] [Related]
32. Malaria, leprosy and dapsone. Saha K; Kapoor L; Arora VM; Chattopadhya D Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):501-4. PubMed ID: 15115119 [TBL] [Abstract][Full Text] [Related]
33. Search for effective short-course regimens for the treatment of leprosy. Pattyn SR Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):76-81. PubMed ID: 8326183 [No Abstract] [Full Text] [Related]
34. [Current concepts in the treatment of Hansen's disease]. Languillon J Acta Leprol; 1980; (81):49-57. PubMed ID: 6785983 [No Abstract] [Full Text] [Related]
35. [Chemotherapy of leprosy. II. Sulfones and sulfonamides]. Leiker DL Ned Tijdschr Geneeskd; 1980 Jan; 124(2):46-8. PubMed ID: 7374822 [No Abstract] [Full Text] [Related]
36. Prospects for chemotherapy of leprosy. Ji B Indian J Lepr; 2000; 72(2):187-98. PubMed ID: 11008659 [No Abstract] [Full Text] [Related]
37. The contribution of "cure by dapsone monotherapy' to the reduction of prevalence of leprosy in the State of Orissa, India, 1983-1993. Patnaik PK; McDougall AC Indian J Lepr; 1996; 68(3):223-6. PubMed ID: 8889607 [TBL] [Abstract][Full Text] [Related]
38. Dapsone-induced agranulocytosis in a patient of leprosy. Mishra M; Chhetia R Indian J Dermatol Venereol Leprol; 2006; 72(6):456-7. PubMed ID: 17179627 [No Abstract] [Full Text] [Related]
39. Progress in the chemotherapy of leprosy. Grosset JH Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):268-77. PubMed ID: 8046266 [No Abstract] [Full Text] [Related]